| Our team researches and develops druggable bioprocessed plant substances, focused on discovering, developing and commercializing innovative Rx pharmaceuticals, biologics and over-the-counter medicine. We work closely with all major "science hubs" and universities worldwide, creating collaborations with academic research scientists and biotech firms to realize product development and commercialization of new therapies. Priorities of our research are elaborated therapy-concepts that minimize side effects and optimize life quality for patients. | ||
| FOCUS | ||
|
- Targeted cancer therapies that block the growth and spread of cancer by interfering with specific genes involved in tumor
growth and progression
- Treatments of vasomotor symptoms, hot flashes and depression in menopausal women |
||
| ANALYTICS | ||
|
- We are using advanced STD-spectroscopy and proteomics to identify potential therapeutic agents and targets
- Attendant-Therapy-Analytics |
||
| PROTEOMICS (study of proteins, particularly their structures and functions) | ||
Identification of protein function in collaboration with other proteins. Identifying which proteins interact in plant substances. This is especially useful in determining potential partners in cell signaling cascades.
|
||
| NMR-STD Spectroscopy | ||
|
- Saturation transfer difference (STD) spectroscopy allows to detect transient binding of small molecule ligands to
macromolecular receptors. - NMR-STD method can be used to determine which part of the ligand molecule is responsible for binding since stronger interacting groups of ligands will show stronger STD effects. STD provides essential information on which molecule out of a compound interacts with the corresponding receptor.
|
